3 completed, 1 active not recruiting, 1 terminated. 4 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Active not recruiting 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Eprex®: new trials by email Literature Review of Eprex® trials Research Report on Eprex®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Anemia (3) · Anemia, Refractory, with Excess of Blasts (1) · Kidney Failure, Chronic (1) · Myelodysplastic Syndromes (1)
Shenyang Sunshine Pharmaceutical Co., LTD. (2) · Celgene (1) · Cinnagen (1) · Sandoz (1)
Austria (2) · Germany (2) · Russia (2) · Thailand (2) · Australia (1) · Belgium (1) · Canada (1) · Czechia (1) · France (1) · Greece (1) · Hungary (1) · Iran (1) · Israel (1) · Italy (1) · Japan (1)
Bolong Miao, Doctoral (1) · Marianne Haag-Weber, Prof. (1)
PMID 30253403, PMID 36451454, PMID 37311468, PMID 39038479, PMID 40377899, PMID 41549790